![Michael Baker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Baker
Directeur Général chez
PERCHERON THERAPEUTICS LIMITED
Fortune : 351 933 $ au 31/08/2026
Profil
Dr. Michael Baker is a Chief Executive Officer & Managing Director at Percheron Therapeutics Ltd. and an Investment Associate at Bioscience Managers Pty Ltd. He is on the Board of Directors at Radiopharm Theranostics (USA), Inc. Dr. Baker was previously employed as an Independent Non-Executive Director by Radiopharm Theranostics Ltd., a Chief Executive Officer, MD & Director by Arovella Therapeutics Ltd., and a Senior Manager by Hexima Ltd. He received his undergraduate degree from La Trobe University, a graduate degree from La Trobe University and an MBA from Melbourne Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/05/2026 | 8 184 493 ( 0,68% ) | 351 933 $ | 31/08/2026 |
Postes actifs de Michael Baker
| Sociétés | Poste | Début |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Directeur Général | 05/10/2026 |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Analyste en capital-investissement | 01/11/2017 |
Radiopharm Theranostics (USA), Inc.
 Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Baker
| Sociétés | Poste | Fin |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Directeur Général | 04/05/2026 |
| RADIOPHARM THERANOSTICS LIMITED | Directeur/Membre du Conseil | 26/03/2024 |
| HEXIMA LIMITED | Corporate Officer/Principal | - |
Formation de Michael Baker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Melbourne Business School
 Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hexima Ltd.
 Hexima Ltd. BiotechnologyHealth Technology Engages in research and development of plant-derived proteins for treatment of fungal nail infections and provides commercial property services | Health Technology |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
LaTrobe University
 LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Radiopharm Theranostics Ltd.
 Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Health Technology |
